NPC1 and infection: Previous publications suggested a dual mechanism of action for several of these antibodies, KZ52, mAb100, and ADI-15946 (28, 30); to block EBOV GP-mediated infection, they hampered post-NPC1-binding steps and interfered with GP’s proteolytic processing in vitro.